Our featured interview this week is with Zynex, Inc.(ZYXI)

The complete interview with Thomas Sandgaard, President & CEO, is now available.

Zynex, Inc. engineers, manufactures, markets and sells its own design of electrotherapy medical devices in two distinct markets: standard digital electrotherapy products for pain relief and pain management; and the NeuroMove(TM) for stroke and spinal cord injury (SCI) rehabilitation. Zynex’s product lines are fully developed, FDA-cleared, commercially sold, an have been developed to uphold the Company’s mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain.

This entry was posted on Friday, September 25th, 2009 at 1:35 pm and is filed under Healthcare Stocks. You can follow any responses to this entry through the RSS 2.0 feed.